Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT07222566 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1410

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Carcinoma, Non-Small-Cell Lung (NSCLC)
Metastatic Non Small Cell Lung Cancer
Lung Cancer

Interventions

BIOLOGICAL: PF-08634404
BIOLOGICAL: Pembrolizumab
DRUG: Chemotherapy Regimen 1
DRUG: Chemotherapy Regimen 2

Sponsor

Pfizer